Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of Point Biopharma Global Inc. on Form S-1 of our report dated March 15, 2021 (except for Notes 11 and 12, as to which the date is April 30, 2021), with respect to our audits of the consolidated financial statements of POINT Biopharma, Inc. and Subsidiaries as of December 31, 2020 and 2019 and for the year ended December 31, 2020 and for the period from September 18, 2019 (inception) through December 31, 2019. We also consent to the reference of our firm under the heading "Experts" in this Registration Statement.
| /s/ ArmaninoLLP | |
| San Jose, California |
July 30, 2021
